Drug information for DANTRIUM
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
100MG
Prescription
AB (Reference Drug)
DANTROLENE SODIUM
Dantrolene
JHP PHARMS
17443
CAPSULE; ORAL
25MG
Prescription
AB
DANTROLENE SODIUM
Dantrolene
JHP PHARMS
"
CAPSULE; ORAL
50MG
Prescription
AB
DANTROLENE SODIUM
Dantrolene
JHP PHARMS
"
INJECTABLE; INJECTION
20MG/VIAL
Prescription
AP (Reference Drug)
DANTROLENE SODIUM
Dantrolene
JHP PHARMS
18264
2008-11-07 Label
2008-10-27 Letter
Drug Adverse Effects information for DANTRIUM
Role code
Indications
Reaction
# Reports
PS
GAIT SPASTIC
DIPLOPIA
3
PS
GAIT SPASTIC
EYE MOVEMENT DISORDER
3
PS
SPINAL LIGAMENT OSSIFICATION
ALTERED STATE OF CONSCIOUSNESS
1
PS
SPINAL LIGAMENT OSSIFICATION
CONDITION AGGRAVATED
1
PS
SPINAL OSTEOARTHRITIS
DIPLOPIA
2
PS
SPINAL OSTEOARTHRITIS
EYE MOVEMENT DISORDER
2
SS
EPILEPSY
APNOEA
1
SS
EPILEPSY
SOMNOLENCE
1
SS
GAIT SPASTIC
DIPLOPIA
3
SS
GAIT SPASTIC
EYE MOVEMENT DISORDER
3
SS
NEUROLEPTIC MALIGNANT SYNDROME
HEPATITIS FULMINANT
1
SS
SPINAL OSTEOARTHRITIS
DIPLOPIA
2
SS
SPINAL OSTEOARTHRITIS
EYE MOVEMENT DISORDER
2
C
ANALGESIC THERAPY
DIZZINESS
1
C
ANALGESIC THERAPY
DRUG EFFECT INCREASED
1
C
ANALGESIC THERAPY
DRUG INEFFECTIVE
1
C
ANALGESIC THERAPY
DRUG INTERACTION
1
C
ANALGESIC THERAPY
DYSARTHRIA
1
C
ANALGESIC THERAPY
NAUSEA
1
C
ANALGESIC THERAPY
SOMNOLENCE
1
C
ANALGESIC THERAPY
VOMITING
1
C
BIPOLAR DISORDER
BLOOD CREATINE PHOSPHOKINASE INCREASED
1
C
BIPOLAR DISORDER
CONFUSIONAL STATE
1
C
BIPOLAR DISORDER
DELIRIUM
1
C
BIPOLAR DISORDER
LETHARGY
1
C
BIPOLAR DISORDER
LUNG INFILTRATION
1
C
BIPOLAR DISORDER
MENTAL DISORDER
1
C
BIPOLAR DISORDER
MUSCULOSKELETAL STIFFNESS
1
C
BIPOLAR DISORDER
NEUROLEPTIC MALIGNANT SYNDROME
1
C
BIPOLAR DISORDER
PNEUMONIA
1
C
BIPOLAR DISORDER
VOMITING
1
C
CEREBRAL PALSY
BRONCHITIS
8
C
CEREBRAL PALSY
CYTOMEGALOVIRUS VIRAEMIA
8
C
CEREBRAL PALSY
DIARRHOEA
8
C
CEREBRAL PALSY
DYSKINESIA
8
C
CEREBRAL PALSY
EYE DISCHARGE
8
C
CEREBRAL PALSY
GASTROINTESTINAL HYPERMOTILITY
8
C
CEREBRAL PALSY
HYPERKALAEMIA
8
C
CEREBRAL PALSY
HYPERTENSION
8
C
CEREBRAL PALSY
HYPOTENSION
8
C
CEREBRAL PALSY
PNEUMONIA ASPIRATION
8
C
CEREBRAL PALSY
URINE OUTPUT DECREASED
8
C
DIARRHOEA
BRONCHITIS
8
C
DIARRHOEA
CYTOMEGALOVIRUS VIRAEMIA
8
C
DIARRHOEA
DIARRHOEA
8
C
DIARRHOEA
DYSKINESIA
8
C
DIARRHOEA
EYE DISCHARGE
8
C
DIARRHOEA
GASTROINTESTINAL HYPERMOTILITY
8
C
DIARRHOEA
HYPERKALAEMIA
8
C
DIARRHOEA
HYPERTENSION
8
C
DIARRHOEA
HYPOTENSION
8
C
DIARRHOEA
PNEUMONIA ASPIRATION
8
C
DIARRHOEA
URINE OUTPUT DECREASED
8
C
DYSKINESIA
BRONCHITIS
4
C
DYSKINESIA
CYTOMEGALOVIRUS VIRAEMIA
4
C
DYSKINESIA
DIARRHOEA
4
C
DYSKINESIA
DYSKINESIA
4
C
DYSKINESIA
EYE DISCHARGE
4
C
DYSKINESIA
GASTROINTESTINAL HYPERMOTILITY
4
C
DYSKINESIA
HYPERKALAEMIA
4
C
DYSKINESIA
HYPERTENSION
4
C
DYSKINESIA
HYPOTENSION
4
C
DYSKINESIA
PNEUMONIA ASPIRATION
4
C
DYSKINESIA
URINE OUTPUT DECREASED
4
C
DYSURIA
DIZZINESS
1
C
DYSURIA
DRUG EFFECT INCREASED
1
C
DYSURIA
DRUG INEFFECTIVE
1
C
DYSURIA
DRUG INTERACTION
1
C
DYSURIA
DYSARTHRIA
1
C
DYSURIA
NAUSEA
1
C
DYSURIA
SOMNOLENCE
1
C
DYSURIA
VOMITING
1
C
EPILEPSY
ANAEMIA
2
C
EPILEPSY
BLISTER
3
C
EPILEPSY
BRONCHITIS
4
C
EPILEPSY
C-REACTIVE PROTEIN INCREASED
3
C
EPILEPSY
CARDIO-RESPIRATORY ARREST
2
C
EPILEPSY
CELLULITIS
3
C
EPILEPSY
CYTOMEGALOVIRUS VIRAEMIA
4
C
EPILEPSY
DIARRHOEA
4
C
EPILEPSY
DYSKINESIA
4
C
EPILEPSY
EOSINOPHIL COUNT DECREASED
3
C
EPILEPSY
ERYTHEMA
3
C
EPILEPSY
EYE DISCHARGE
7
C
EPILEPSY
GASTROINTESTINAL HAEMORRHAGE
1
C
EPILEPSY
GASTROINTESTINAL HYPERMOTILITY
4
C
EPILEPSY
HYPERAEMIA
3
C
EPILEPSY
HYPERKALAEMIA
4
C
EPILEPSY
HYPERTENSION
4
C
EPILEPSY
HYPOTENSION
4
C
EPILEPSY
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY
1
C
EPILEPSY
LYMPHOCYTE COUNT INCREASED
3
C
EPILEPSY
MONOCYTE COUNT INCREASED
3
C
EPILEPSY
NEUTROPHIL COUNT DECREASED
3
C
EPILEPSY
PNEUMONIA ASPIRATION
4
C
EPILEPSY
PYREXIA
3
C
EPILEPSY
RASH PUSTULAR
3
C
EPILEPSY
SKIN NECROSIS
3
C
EPILEPSY
STEVENS-JOHNSON SYNDROME
3
C
EPILEPSY
URINE OUTPUT DECREASED
4
C
EPILEPSY
WRONG TECHNIQUE IN DRUG USAGE PROCESS
2
C
GASTROOESOPHAGEAL REFLUX DISEASE
DIZZINESS
1
C
GASTROOESOPHAGEAL REFLUX DISEASE
DRUG EFFECT INCREASED
1
C
GASTROOESOPHAGEAL REFLUX DISEASE
DRUG INEFFECTIVE
1
C
GASTROOESOPHAGEAL REFLUX DISEASE
DRUG INTERACTION
1
C
GASTROOESOPHAGEAL REFLUX DISEASE
DYSARTHRIA
1
C
GASTROOESOPHAGEAL REFLUX DISEASE
NAUSEA
1
C
GASTROOESOPHAGEAL REFLUX DISEASE
SOMNOLENCE
1
C
GASTROOESOPHAGEAL REFLUX DISEASE
VOMITING
1
C
HYPERKALAEMIA
BRONCHITIS
4
C
HYPERKALAEMIA
CYTOMEGALOVIRUS VIRAEMIA
4
C
HYPERKALAEMIA
DIARRHOEA
4
C
HYPERKALAEMIA
DYSKINESIA
4
C
HYPERKALAEMIA
EYE DISCHARGE
4
C
HYPERKALAEMIA
GASTROINTESTINAL HYPERMOTILITY
4
C
HYPERKALAEMIA
HYPERKALAEMIA
4
C
HYPERKALAEMIA
HYPERTENSION
4
C
HYPERKALAEMIA
HYPOTENSION
4
C
HYPERKALAEMIA
PNEUMONIA ASPIRATION
4
C
HYPERKALAEMIA
URINE OUTPUT DECREASED
4
C
HYPOTHYROIDISM
BRONCHITIS
4
C
HYPOTHYROIDISM
CYTOMEGALOVIRUS VIRAEMIA
4
C
HYPOTHYROIDISM
DIARRHOEA
4
C
HYPOTHYROIDISM
DYSKINESIA
4
C
HYPOTHYROIDISM
EYE DISCHARGE
4
C
HYPOTHYROIDISM
GASTROINTESTINAL HYPERMOTILITY
4
C
HYPOTHYROIDISM
HYPERKALAEMIA
4
C
HYPOTHYROIDISM
HYPERTENSION
4
C
HYPOTHYROIDISM
HYPOTENSION
4
C
HYPOTHYROIDISM
PNEUMONIA ASPIRATION
4
C
HYPOTHYROIDISM
URINE OUTPUT DECREASED
4
C
INFECTION
ANAPHYLACTIC REACTION
1
C
INFECTION PROPHYLAXIS
BRONCHITIS
4
C
INFECTION PROPHYLAXIS
CYTOMEGALOVIRUS VIRAEMIA
4
C
INFECTION PROPHYLAXIS
DIARRHOEA
4
C
INFECTION PROPHYLAXIS
DYSKINESIA
4
C
INFECTION PROPHYLAXIS
EYE DISCHARGE
4
C
INFECTION PROPHYLAXIS
GASTROINTESTINAL HYPERMOTILITY
4
C
INFECTION PROPHYLAXIS
HYPERKALAEMIA
4
C
INFECTION PROPHYLAXIS
HYPERTENSION
4
C
INFECTION PROPHYLAXIS
HYPOTENSION
4
C
INFECTION PROPHYLAXIS
PNEUMONIA ASPIRATION
4
C
INFECTION PROPHYLAXIS
URINE OUTPUT DECREASED
4
C
MINERAL SUPPLEMENTATION
DIZZINESS
1
C
MINERAL SUPPLEMENTATION
DRUG EFFECT INCREASED
1
C
MINERAL SUPPLEMENTATION
DRUG INEFFECTIVE
1
C
MINERAL SUPPLEMENTATION
DRUG INTERACTION
1
C
MINERAL SUPPLEMENTATION
DYSARTHRIA
1
C
MINERAL SUPPLEMENTATION
NAUSEA
1
C
MINERAL SUPPLEMENTATION
SOMNOLENCE
1
C
MINERAL SUPPLEMENTATION
VOMITING
1
C
MULTIPLE SCLEROSIS RELAPSE
BLISTER
1
C
MULTIPLE SCLEROSIS RELAPSE
BURNING SENSATION
1
C
MULTIPLE SCLEROSIS RELAPSE
ERYTHEMA
1
C
MULTIPLE SCLEROSIS RELAPSE
PRURITUS
1
C
MULTIPLE SCLEROSIS RELAPSE
RASH
1
C
MUSCLE SPASTICITY
IMPLANT SITE EFFUSION
1
C
MUSCLE SPASTICITY
IMPLANT SITE HAEMATOMA
1
C
MUSCLE SPASTICITY
IMPLANT SITE OEDEMA
1
C
MUSCLE SPASTICITY
RESIDUAL URINE VOLUME INCREASED
1
C
MUSCLE TIGHTNESS
BLISTER
2
C
MUSCLE TIGHTNESS
C-REACTIVE PROTEIN INCREASED
2
C
MUSCLE TIGHTNESS
CELLULITIS
2
C
MUSCLE TIGHTNESS
EOSINOPHIL COUNT DECREASED
2
C
MUSCLE TIGHTNESS
ERYTHEMA
2
C
MUSCLE TIGHTNESS
EYE DISCHARGE
2
C
MUSCLE TIGHTNESS
HYPERAEMIA
2
C
MUSCLE TIGHTNESS
LYMPHOCYTE COUNT INCREASED
2
C
MUSCLE TIGHTNESS
MONOCYTE COUNT INCREASED
2
C
MUSCLE TIGHTNESS
NEUTROPHIL COUNT DECREASED
2
C
MUSCLE TIGHTNESS
PYREXIA
2
C
MUSCLE TIGHTNESS
RASH PUSTULAR
2
C
MUSCLE TIGHTNESS
SKIN NECROSIS
2
C
MUSCLE TIGHTNESS
STEVENS-JOHNSON SYNDROME
2
C
PAIN
DIZZINESS
6
C
PAIN
DRUG EFFECT INCREASED
6
C
PAIN
DRUG INEFFECTIVE
6
C
PAIN
DRUG INTERACTION
6
C
PAIN
DYSARTHRIA
6
C
PAIN
NAUSEA
6
C
PAIN
SOMNOLENCE
6
C
PAIN
VOMITING
6
C
PAIN MANAGEMENT
ARRHYTHMIA
1
C
PROPHYLAXIS
DIZZINESS
2
C
PROPHYLAXIS
DRUG EFFECT INCREASED
2
C
PROPHYLAXIS
DRUG INEFFECTIVE
2
C
PROPHYLAXIS
DRUG INTERACTION
2
C
PROPHYLAXIS
DYSARTHRIA
2
C
PROPHYLAXIS
NAUSEA
2
C
PROPHYLAXIS
SOMNOLENCE
2
C
PROPHYLAXIS
VOMITING
2
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
BRONCHITIS
8
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
CYTOMEGALOVIRUS VIRAEMIA
8
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
DIARRHOEA
8
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
DYSKINESIA
8
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
EYE DISCHARGE
8
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
GASTROINTESTINAL HYPERMOTILITY
8
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
HYPERKALAEMIA
8
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
HYPERTENSION
8
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
HYPOTENSION
8
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
PNEUMONIA ASPIRATION
8
C
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER
URINE OUTPUT DECREASED
8
C
RENAL TRANSPLANT
BRONCHITIS
20
C
RENAL TRANSPLANT
CYTOMEGALOVIRUS VIRAEMIA
20
C
RENAL TRANSPLANT
DIARRHOEA
20
C
RENAL TRANSPLANT
DYSKINESIA
20
C
RENAL TRANSPLANT
EYE DISCHARGE
20
C
RENAL TRANSPLANT
GASTROINTESTINAL HYPERMOTILITY
20
C
RENAL TRANSPLANT
HYPERKALAEMIA
20
C
RENAL TRANSPLANT
HYPERTENSION
20
C
RENAL TRANSPLANT
HYPOTENSION
20
C
RENAL TRANSPLANT
PNEUMONIA ASPIRATION
20
C
RENAL TRANSPLANT
URINE OUTPUT DECREASED
20
C
SCHIZOPHRENIA
BLOOD CREATINE PHOSPHOKINASE INCREASED
1
C
SCHIZOPHRENIA
CONFUSIONAL STATE
1
C
SCHIZOPHRENIA
DELIRIUM
1
C
SCHIZOPHRENIA
LETHARGY
1
C
SCHIZOPHRENIA
LUNG INFILTRATION
1
C
SCHIZOPHRENIA
MENTAL DISORDER
1
C
SCHIZOPHRENIA
MUSCULOSKELETAL STIFFNESS
1
C
SCHIZOPHRENIA
NEUROLEPTIC MALIGNANT SYNDROME
1
C
SCHIZOPHRENIA
PNEUMONIA
1
C
SCHIZOPHRENIA
VOMITING
1
C
SEDATIVE THERAPY
BRONCHITIS
16
C
SEDATIVE THERAPY
CYTOMEGALOVIRUS VIRAEMIA
16
C
SEDATIVE THERAPY
DIARRHOEA
16
C
SEDATIVE THERAPY
DYSKINESIA
16
C
SEDATIVE THERAPY
EYE DISCHARGE
16
C
SEDATIVE THERAPY
GASTROINTESTINAL HYPERMOTILITY
16
C
SEDATIVE THERAPY
HYPERKALAEMIA
16
C
SEDATIVE THERAPY
HYPERTENSION
16
C
SEDATIVE THERAPY
HYPOTENSION
16
C
SEDATIVE THERAPY
PNEUMONIA ASPIRATION
16
C
SEDATIVE THERAPY
URINE OUTPUT DECREASED
16
C
SEPSIS
AGRANULOCYTOSIS
1
C
SEPSIS
MACULE
1
C
THROMBOSIS PROPHYLAXIS
BRONCHITIS
8
C
THROMBOSIS PROPHYLAXIS
CYTOMEGALOVIRUS VIRAEMIA
8
C
THROMBOSIS PROPHYLAXIS
DIARRHOEA
8
C
THROMBOSIS PROPHYLAXIS
DYSKINESIA
8
C
THROMBOSIS PROPHYLAXIS
EYE DISCHARGE
8
C
THROMBOSIS PROPHYLAXIS
GASTROINTESTINAL HYPERMOTILITY
8
C
THROMBOSIS PROPHYLAXIS
HYPERKALAEMIA
8
C
THROMBOSIS PROPHYLAXIS
HYPERTENSION
8
C
THROMBOSIS PROPHYLAXIS
HYPOTENSION
8
C
THROMBOSIS PROPHYLAXIS
PNEUMONIA ASPIRATION
8
C
THROMBOSIS PROPHYLAXIS
URINE OUTPUT DECREASED
8
C
VITAMIN SUPPLEMENTATION
DIZZINESS
1
C
VITAMIN SUPPLEMENTATION
DRUG EFFECT INCREASED
1
C
VITAMIN SUPPLEMENTATION
DRUG INEFFECTIVE
1
C
VITAMIN SUPPLEMENTATION
DRUG INTERACTION
1
C
VITAMIN SUPPLEMENTATION
DYSARTHRIA
1
C
VITAMIN SUPPLEMENTATION
NAUSEA
1
C
VITAMIN SUPPLEMENTATION
SOMNOLENCE
1
C
VITAMIN SUPPLEMENTATION
VOMITING
1
Ads by Google